Literature DB >> 6476075

Effects of iron overload on bone remodeling in pigs.

M C de Vernejoul, A Pointillart, C C Golenzer, C Morieux, J Bielakoff, D Modrowski, L Miravet.   

Abstract

For study of the effects of an iron overload on bone remodeling, 5 control pigs were compared with 5 pigs given a total dose of 10.8 g of parenteral iron in 36 days. Treated pigs developed an iron tissue overload demonstrated by a marked increase in bone and liver iron. Except for a modest increase in SGOT, there was no biochemical or histologic sign of liver damage. Serum levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D were unchanged in the treated pigs. There was no accumulation of iron in the parathyroid glands and the serum immunoreactive parathyroid hormone level was unchanged in the treated animals. Bone histomorphometry after double tetracycline labeling showed that in the treated pigs osteoblast cell surfaces, double and total labeled surfaces, appositional rate, and formation at tissue level were significantly decreased, and reversal surfaces were increased. Mineralization was not impaired because the osteoid thickness was unchanged. From the morphometric measurements it was concluded that osteoblast recruitment and the collagen synthesis rate were decreased. Mean wall thickness, which indicates the amount of bone synthesized, was also lowered. In contrast, the osteoclastic resorption surfaces and the depth of lacunae resulting from osteoclast resorption were unchanged by treatment. Despite this imbalance between formation and resorption, trabecular bone mass estimated on trabecular bone volume and bone ash was unchanged after 36 days' treatment. Perls' stain revealed that iron deposits were present in osteoblast and osteoclast cells and also inside the bone matrix, because there was a linear deposit along the trabecular surfaces, cement line, and osteoid-mineralized bone interface. Therefore, because treatment induced no modification of the major humoral regulators of bone metabolism, it is suggested that iron, which was present in bone cells and matrix, could play a role in bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476075      PMCID: PMC1900459     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Distribution of storage iron as body stores expand in patients with hemochromatosis.

Authors:  L S Valberg; J B Simon; P N Manley; W E Corbett; J Ludwig
Journal:  J Lab Clin Med       Date:  1975-09

2.  Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis.

Authors:  B Brink; P Disler; S Lynch; P Jacobs; R Charlton; T Bothwell
Journal:  J Lab Clin Med       Date:  1976-11

3.  [Bone histomorphometry and osteo-articular manifestations of idiopathic hemochromatosis].

Authors:  Y Pawlotsky; Y Lancien; G Roudier; Y Hany; J Y Louboutin; B Ferrand; M Bourel
Journal:  Rev Rhum Mal Osteoartic       Date:  1979-02

4.  The effect of siderosis and ascorbic acid depletion on bone metabolism, with special reference to osteoporosis in the Bantu.

Authors:  A A Wapnick; S R Lynch; H C Seftel; R W Charlton; T H Bothwell; J Jowsey
Journal:  Br J Nutr       Date:  1971-05       Impact factor: 3.718

5.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

6.  Measurement of liver-iron concentration in needle-biopsy specimens.

Authors:  M Barry; S Sherlock
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

7.  Studies of vitamin D deficiency in man.

Authors:  M A Preece; C A Ribot; J Pietrek; H T Korn; D M Davies; J A Ford; M G Dunnigan; J L O'Riordan
Journal:  Q J Med       Date:  1975-10

8.  Diagnostic value of bone marrow iron deposits in idiopathic hemochromatosis.

Authors:  A A Cooperberg; A Rosenberg; J P Schwartz
Journal:  Arch Intern Med       Date:  1977-06

9.  Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.

Authors:  P Brissot; M Bourel; D Herry; J P Verger; M Messner; C Beaumont; F Regnouard; B Ferrand; M Simon
Journal:  Gastroenterology       Date:  1981-03       Impact factor: 22.682

10.  Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload.

Authors:  R Gokal; P R Millard; D J Weatherall; S T Callender; J G Ledingham; D O Oliver
Journal:  Q J Med       Date:  1979-07
View more
  25 in total

1.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

2.  Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease.

Authors:  T Diamond; R Pojer; D Stiel; A Alfrey; S Posen
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

3.  Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.

Authors:  Bin Chen; Guang-Fei Li; Ying Shen; X I Huang; You-Jia Xu
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

4.  Different schedules of administration of (3 amino-1-hydroxypropylidene)-1, 1 bisphosphonate induce different changes in pig bone remodeling.

Authors:  M C de Vernejoul; A Pointillart; C Bergot; J Bielakoff; C Morieux; A M Laval Jeantet; L Miravet
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

5.  Skeletal and soft tissue response to automated, continuous, curvilinear distraction osteogenesis.

Authors:  Zachary S Peacock; Brad J Tricomi; Matthew E Lawler; William C Faquin; John C Magill; Brian A Murphy; Leonard B Kaban; Maria J Troulis
Journal:  J Oral Maxillofac Surg       Date:  2014-01-16       Impact factor: 1.895

6.  Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: the 2008-2010 Korea National Health and Nutrition Examination Surveys.

Authors:  Kyung Shik Lee; Ji Su Jang; Dong Ryul Lee; Yang Hyun Kim; Ga Eun Nam; Byoung-Duck Han; Kyung Do Han; Kyung Hwan Cho; Seon Mee Kim; Youn Seon Choi; Do Hoon Kim
Journal:  J Bone Miner Metab       Date:  2013-12-14       Impact factor: 2.626

7.  Spontaneous multiple vertebral fractures revealed primary haemochromatosis.

Authors:  M Duquenne; V Rohmer; E Legrand; D Chappard; N Wion Barbot; M F Basle; M Audran; J C Bigorgne
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

8.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

9.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

10.  Automated continuous distraction osteogenesis may allow faster distraction rates: a preliminary study.

Authors:  Zachary S Peacock; Brad J Tricomi; Brian A Murphy; John C Magill; Leonard B Kaban; Maria J Troulis
Journal:  J Oral Maxillofac Surg       Date:  2013-03-15       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.